The Board of Directors in its meeting held today i.e. 14.02.2025, inter-alia, considered and approved the unaudited Standalone and Consolidated Financial Results of the Company for quarter and nine months ended December 31, 2024. The said results are enclosed herewith as annexure.

pdf

Panacea Biotec Ltd.

14 Feb 2025

427.45

-4.15%

Board Meeting

PANACEA BIOTEC LTD. - 531349 - Board Meeting Outcome for 1. Unaudited Financial Results For The …

BSE India

Please find attached outcome of the Board Meeting of Panacea Biotec Limited held on February 14, 2025

pdf

Panacea Biotec Ltd.

13 Feb 2025

427.45

-4.15%

Company Update

PANACEA BIOTEC LTD. - 531349 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And …

BSE India

The Board of Directors'' of the Company''s material subsidiary, Panacea Biotec Pharma Limited ("PBPL") has, in its meeting held on 13.02.2025, appointed Dr. Sanjay Trehan as Whole-time Director for a term of 3 years w.e.f. 13.02.2025. We would also like to inform the change in Senior Management Personnel of PBPL due to change in internal role, responsibilities and reporting structure. The details pursuant to the SEBI Circular dated 13.07.2023 is attached herewith.

pdf

Panacea Biotec Ltd.

07 Feb 2025

427.45

-4.15%

Company Update

PANACEA BIOTEC LTD. - 531349 - Demat Report For The Month Of January, 2025

BSE India

Please find attached the details of shares dematerialised during January 2025 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018

pdf

Panacea Biotec Ltd.

31 Jan 2025

427.45

-4.15%

Board Meeting

PANACEA BIOTEC LTD. - 531349 - Board Meeting Intimation for Approval Of Standalone And Consolidated Unaudited …

BSE India

PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and nine months ended December 31, 2024. The trading window of the Company shall remain closed for all Designated Persons till February 16, 2025.

pdf

Panacea Biotec Ltd.

23 Jan 2025

427.45

-4.15%

Company Update

PANACEA BIOTEC LTD. - 531349 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

In continuation to our earlier communication dated 20.08.2024 regarding receipt of demand order, we are pleased to inform you that the Hon''ble Bombay High Court has set aside the demand order on 22.01.2025 and the matter has been remanded back to Assistant Commissioner of Sales Tax, Mumbai for a fresh adjudication on the show cause notice.

pdf

Panacea Biotec Ltd.

07 Jan 2025

427.45

-4.15%

Company Update

PANACEA BIOTEC LTD. - 531349 - Details Of Shares Dematerialized During December 2024

BSE India

This is to inform that no share has been dematerialized during December 2024. A certificate received from RTA in this regard is also enclosed herewith alongwith demat status report for December 2024

pdf

Is Panacea Biotec Ltd. worth buying?

222 Votes:

Buy 77.03%

Sell 13.51%

Hold 9.46%